|
Sun Pharma Advanced Research Company Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
6629.33 Cr.
|
P/BV
|
4.95
|
Book Value (Rs.)
|
41.26
|
|
52 Week High/Low (Rs.)
|
289/108
|
FV/ML
|
1/1
|
P/E(X)
|
4.27
|
|
Bookclosure
|
30/09/2020
|
EPS (Rs.)
|
47.86
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 25.95 | 44.58 | 58.99 |
| Total Income From Operations | 25.95 | 44.58 | 58.99 |
| | | | |
| EXPENDITURE | | | |
| Consumption of Raw Materials | 18.44 | 17.42 | 20.67 |
| Employees Cost | 92.01 | 123.73 | 91.81 |
| Depreciation | 7.81 | 9.44 | 9.44 |
| Other Expenses | 89.94 | 173.39 | 242.78 |
| Total Expenses | 208.20 | 323.98 | 364.70 |
| | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -182.25 | -279.40 | -305.71 |
| Other Income | 9.15 | 1.79 | 25.07 |
| P/L Before Interest, Excpt. Items & Tax | -173.10 | -277.61 | -280.64 |
| Interest | 22.49 | 4.50 | 0.78 |
| P/L Before Exceptional Items & Tax | -195.59 | -282.11 | -281.42 |
| Exceptional Items | -12.36 | 0.00 | 0.00 |
| P/L Before Tax | -207.95 | -282.11 | -281.42 |
| Tax | 0.19 | 0.63 | 0.00 |
| P/L After Tax from Ordinary Activities | -208.14 | -282.74 | -281.42 |
| Net Profit/Loss For the Period | -208.14 | -282.74 | -281.42 |
| Net P/L After Minority Interest & Share Of Associates | -208.14 | -282.74 | -281.42 |
| | | | |
| Equity Share Capital | 32.45 | 32.45 | 32.45 |
| EPS Before Extra Ordinary * | | | |
| Basic EPS (Rs.) | -6.41 | -8.71 | -8.67 |
| Diluted EPS (Rs.) | (6.41) | (8.71) | -8.67 |
| EPS After Extra Ordinary * | | | |
| Basic EPS (Rs.) | -6.41 | -8.71 | -8.67 |
| Diluted EPS (Rs.) | (6.41) | (8.71) | -8.67 |
| | | | |
| PBITOE Margin (%) | -702.31 | -626.73 | -518.24 |
| PBTE Margin (%) | -753.71 | -632.81 | -477.06 |
| PBT Margin (%) | -801.34 | -632.81 | -477.06 |
| PAT Margin (%) | -802.08 | -634.23 | -477.06 |
| PAT After MI And SOA Margin (%) | -802.08 | -634.23 | -477.06 |
